Category:
Anti-tumor Preparations
Standard:
N;
a microtubule inhibitor indicated for the treatment of:
1.Metastatic breast cancer, after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy.Prior therapy should have included an anthracycline unless clinically contraindicated
2.Locally advanced or metastatic non-small cell lung cancer (NSCLC), as first-line treatment in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy.
3.Metastatic adenocarcinoma of the pancreas as first-line treatment, in combination with gemcitabine.